Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol in ALS
NCT04245709Phase 2Completed
- Start
- Feb 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clenbuterol in amyotrophic lateral sclerosis (ALS). Started Feb 2020; status: completed.
02
Drugs
clenbuterol
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04245709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04245709.